Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    nct00827411
Previous Study | Return to List | Next Study

Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy (ARCTIC)

This study has been completed.
Allies in Cardiovascular Trials Initiatives and Organized
Institut National de la Santé Et de la Recherche Médicale, France
Bristol-Myers Squibb
Cordis Corporation
Fondation de France
Diagnostica Stago
Boston Scientific Corporation
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: January 13, 2009
Last updated: April 11, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):